Abstract: The present invention is concerned with an insect repellent composition and a method of using the same to repel insects over an extended period of time. The compositions of the invention include natural insect repellents and can provide a prolongation of complete protection times to a 12 hour minimum thereby enabling a once daily dosage regime if required.

Abstract: The present invention relates to a conjugate suitable for topical application to the skin of a user, the conjugate comprising at least one volatile active coupled directly or indirectly to a carrier substance, wherein the carrier substance is substantially resistant to permeation through the skin of a user under ambient conditions, and wherein the coupling between the active and the carrier substance is such that said coupling is cleaved under said ambient conditions when said conjugate has been applied to the skin of a user, so as to release said volatile active from said carrier substance in a sustained release manner. The present invention also relates to a composition including such a conjugate and also processes of preparing such conjugates and compositions.

Abstract: The present invention is concerned with an insect repellent composition and a method of using the same to repel insects over an extended period of time. The compositions of the invention include natural insect repellents and can provide a prolongation of complete protection times to a 12 hour minimum thereby enabling a once daily dosage regime if required.

Abstract: The present invention is concerned with an insect repellent composition and a method of using the same to repel insects over an extended period of time. The compositions of the invention include natural insect repellents and can provide a prolongation of complete protection times to a 12 hour minimum thereby enabling a once daily dosage regime if required.

Abstract: The present invention is concerned with an insect repellent composition and a method of using the same to repel insects over an extended period of time. The compositions of the invention include natural insect repellents and can provide a prolongation of complete protection times to a 12 hour minimum thereby enabling a once daily dosage regime if required.

Abstract: The present invention relates to a conjugate suitable for topical application to the skin of a user, the conjugate comprising at least one volatile active coupled directly or indirectly to a carrier substance, wherein the carrier substance is substantially resistant to permeation through the skin of a user under ambient conditions, and wherein the coupling between the active and the carrier substance is such that said coupling is cleaved under said ambient conditions when said conjugate has been applied to the skin of a user, so as to release said volatile active from said carrier substance in a sustained release manner. The present invention also relates to a composition including such a conjugate and also processes of preparing such conjugates and compositions.

Abstract: The invention relates to newly identified uses of HCN channel polypeptides and polynucleotides encoding such polypeptides, to their use in therapy and in identifying compounds which may be antagonists and/or inhibitors which are potentially useful in therapy, and to production of such polypeptides and polynucleotides.

Abstract: A method for the preparation of a two-phase magnetic material that includes as the major phase a crystalline alloy of one or more rare earth metals, boron and iron, substantially all of the crystallites of which have a size of less than 35 nanometers, and as the minor phase .alpha.-Fe, involves the steps of (i) melt spinning an alloy consisting of up to 12 atomic percent of one or more rare earth metals, 3 to 7 atomic percent of boron and the balance iron or a mixture of iron and cobalt; (ii) quenching the melt spun alloy form step (i) under conditions such that a mixture of crystalline and amorphous material is produced, (iii) subjecting the material from step (ii) to an annealing treatment under conditions such that controlled crystal growth occurs to provide the crystalline alloy phase, substantially all of which has a particle size of less than 35 nanometers, the resulting materials having a remanence in excess of the theoretical value of 0.8 Tesla.